| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |